142406-11-9Relevant academic research and scientific papers
LIPOXYGENASE INHIBITORS
-
Paragraph 00417-00419, (2021/10/02)
Various embodiments of the present disclosure are directed to compounds having Formula (I), Formula (IA), Formula (IB), Formula (IC), Formula (ID), Formula (IE), and/or pharmaceutically acceptable salts thereof. The compounds can be suitable for inhibiting lipoxygenases, and/or treating associated diseases, such as Alzheimer's disease. In some embodiments, the compounds may be administered to a patient as part of a pharmaceutical formulation.
Furan Derivatives. Part 13. Synthesis of Thiopyranobenzofuran
Horaguchi, Takaaki,Hasegawa, Kohei,Hasegawa, Eietsu,Shimizu, Takahachi,Tanemura, Kiyoshi,Suzuki, Tsuneo
, p. 503 - 509 (2007/10/02)
Thiopyranobenzofuran 9 possessing benzofuran and methylenethiopyran structures in the molecule was synthesized starting from 1-chloro-4-methoxy-2-nitrobenzene 11.Some reactions (formylation, protonation and catalytic hydrogenation) on 9 were examined.The 2-position of 9 was highly reactive toward electrophilic reagents and the furan ring was readily reduced by catalytic hydrogenation with palladium-charcoal.Thiopyranobenzofuran 9 has both properties of methylenethiopyran and benzofuran.
